Skip to content

Exploring the use of a non-pharmaceutical method to treat drooling in Parkinson's disease

Exploring the feasibility of using high-intensity expiratory muscle strength training to reduce drooling in people with Parkinson's disease

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618001602213
Enrollment
16
Registered
2018-09-27
Start date
2019-06-03
Completion date
2021-02-01
Last updated
2021-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study will explore the feasibility of expiratory muscle strength training (EMST), as a novel, non-invasive treatment approach to reduce drooling in people who have Parkinson's disease (PD). The intervention involves breathing into a threshold loading device. The intervention will take place over a 6 week period and will involve both supervised and unsupervised practice. We hypothesise that EMST will be feasible and well tolerated in this population and will reduce drooling in people with PD by strengthening the muscles associated with lip closure and swallowing.

Interventions

This study will explore the feasibility of expiratory muscle strength training (EMST), as a novel, non-invasive treatment approach to reduce drooling in people with PD. We hypothesise that EMST will be feasible and well tolerated in this population and will reduce drooling by strengthening the muscles associated with lip closure and swallowing (Pitts et al., 2009; Troche et al., 2010). This study will collect measures related to feasibility of the intervention, as well as swallowing, drooling, a

This study will explore the feasibility of expiratory muscle strength training (EMST), as a novel, non-invasive treatment approach to reduce drooling in people with PD. We hypothesise that EMST will be feasible and well tolerated in this population and will reduce drooling by strengthening the muscles associated with lip closure and swallowing (Pitts et al., 2009; Troche et al., 2010). This study will collect measures related to feasibility of the intervention, as well as swallowing, drooling, and tongue and lip muscle strength before and after a 6 weeks program of high-intensity EMST training. Supervised training will take place twice a week for six weeks with a speech pathologist at Bentley Hospital. Participants will also be prescribed to complete EMST at home on an additional three days each week (unsupervised). Adherence will be monitored during these unsupervised practice sessions by participants keeping a diary of home practice. During each session, EMST will be conducted using a threshold loading device (EMST 150 device: https://emst150.com/), with the initial training load prescribed at 50% of their baseline maximum expiratory pressure. Participants will perform the EMST in sitting, wearing a nose clip. They will be instructed to breathe at their usual rate and depth. An interval-based training approach will be used to optimise the training load that can be tolerated. Specifically, participants will be asked to breathe with a single forced expiration, followed by a 15 second rest. This is repeated 25 times with a one minute rest every five breaths. During each supervised training session, participants will have their arterial oxygen saturation monitored continuously (via a pulse oximeter) and, at the end of each five breath work interval, they will be asked to rate their perceived exertion (using the 0 to 10 Borg category ratio scale). Training loads will be progressed as quickly as possible with the goal of having the load during the final two-minute work interval perceived as ‘very hard’ (7/10 on the Borg scale) with participants unable to consistently maintain lip closure during their expiratory efforts. The aim of this intervention is to strengthen the muscles required for lip closure and swallowing and thus reduce drooling.

Sponsors

Curtin University
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

A diagnosis of Parkinson's disease and reported difficulties with drooling. Attends recruitment hospital.

Exclusion criteria

An inability to understand written or spoken English. Evidence of moderate-severe cognitive impairment. Unable to obtain medical clearance from doctor.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026